Ruklanthi de Alwis
Overview
Explore the profile of Ruklanthi de Alwis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
1461
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khoo Y, Wulandari S, Getchell M, Moe L, Kumar S, Liu E, et al.
Cell Genom
. 2025 Feb;
5(3):100781.
PMID: 40020687
Sustaining and expanding genomic surveillance capacity requires broader investment in genomics that target both novel and pandemic pathogens. Currently, there is no standardized methodology to evaluate the cost and benefit...
2.
Getchell M, Wulandari S, de Alwis R, Agoramurthy S, Khoo Y, Mak T, et al.
Nat Microbiol
. 2024 Oct;
10(1):258.
PMID: 39414934
No abstract available.
3.
Getchell M, Wulandari S, de Alwis R, Agoramurthy S, Khoo Y, Mak T, et al.
Nat Microbiol
. 2024 Sep;
9(10):2738-2747.
PMID: 39317773
Asia remains vulnerable to new and emerging infectious diseases. Understanding how to improve next generation sequencing (NGS) use in pathogen surveillance is an urgent priority for regional health security. Here...
4.
Pronyk P, de Alwis R, Rockett R, Basile K, Boucher Y, Pang V, et al.
Cell Genom
. 2023 Dec;
3(12):100443.
PMID: 38116115
Genomic sequencing has emerged as a powerful tool to enhance early pathogen detection and characterization with implications for public health and clinical decision making. Although widely available in developed countries,...
5.
Jones N, Thu T, de Alwis R, Thompson C, Tuyen H, Nhu T, et al.
PLoS Negl Trop Dis
. 2023 Oct;
17(10):e0011728.
PMID: 37903147
Background: Shigella sonnei is a pathogen of growing global importance as a cause of diarrhoeal illness in childhood, particularly in transitional low-middle income countries (LMICs). Here, we sought to determine...
6.
Low J, de Alwis R, Chen S, Kalimuddin S, Leong Y, Mah T, et al.
NPJ Vaccines
. 2022 Dec;
7(1):161.
PMID: 36513697
Coronavirus disease-19 (Covid-19) pandemic have demonstrated the importantance of vaccines in disease prevention. Self-amplifying mRNA vaccines could be another option for disease prevention if demonstrated to be safe and immunogenic....
7.
Ong E, Yee J, Ooi J, Syenina A, de Alwis R, Chen S, et al.
NPJ Vaccines
. 2022 Nov;
7(1):154.
PMID: 36443317
Remarkable potency has been demonstrated for mRNA vaccines in reducing the global burden of the ongoing COVID-19 pandemic. An alternative form of the mRNA vaccine is the self-amplifying mRNA (sa-mRNA)...
8.
Seneviratne C, Balan P, de Alwis R, Udawatte N, Herath T, Toh J, et al.
Int Dent J
. 2022 Nov;
73(3):435-442.
PMID: 36402577
Objectives: The COVID-19 vaccine is currently being administered worldwide to address the ongoing pandemic. Although these vaccines have proven effective in preventing severe disease, the level of immunity required to...
9.
Syenina A, Gan E, Toh J, de Alwis R, Lin L, Tham C, et al.
PLoS Biol
. 2022 May;
20(5):e3001643.
PMID: 35639676
Ensuring high vaccination and even booster vaccination coverage is critical in preventing severe Coronavirus Disease 2019 (COVID-19). Among the various COVID-19 vaccines currently in use, the mRNA vaccines have shown...
10.
Tiu C, Zhu F, Wang L, de Alwis R
Pathogens
. 2022 May;
11(5).
PMID: 35631089
Phage ImmunoPrecipitation Sequencing (PhIP-Seq) is a high throughput serological technology that is revolutionizing the manner in which we track antibody profiles. In this review, we mainly focus on its application...